ROYCE & ASSOCIATES LP

Position in ALKS — Alkermes plc.

CIK 906304 New York, NY

Position in ALKS

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$1,968,950

+$625,631 QoQ

Shares Held

55,683

+16.0% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $63,128,523 across 14 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SUPN	Supernus Pharmaceuticals, Inc.	229,939	$11,885,546
2	ELAN	Elanco Animal Health Inc	469,916	$11,245,089
3	PBH	Prestige Consumer Healthcare Inc.	157,126	$9,312,858
4	COLL	Collegium Pharmaceutical, Inc	272,786	$9,021,033
5	AMPH	Amphastar Pharmaceuticals, Inc.	406,175	$7,956,968
6	SIGA	Siga Technologies Inc	667,646	$3,571,906
7	TKNO	Alpha Teknova, Inc.	1,069,162	$3,089,878
8	ALKS	Alkermes plc. This page	55,683	$1,968,950

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,968,950	55,683	+16.0%	Shares	Sole	2026-05-12
2025-12-31	$1,343,319	48,010	-3.5%	Shares	Sole	2026-02-09
2025-09-30	$1,493,070	49,769	+0.1%	Shares	Sole	2025-11-12
2025-06-30	$1,422,832	49,732	+5.4%	Shares	Sole	2025-08-11
2025-03-31	$1,558,114	47,187	-13.3%	Shares	Sole	2025-05-06
2024-12-31	$1,565,435	54,431	-19.5%	Shares	Sole	2025-02-10
2024-09-30	$1,892,907	67,628	+49.4%	Shares	Sole	2024-11-06
2024-06-30	$1,091,055	45,272	+42.2%	Shares	Sole	2024-08-13
2024-03-31	$862,071	31,846	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.